Navigation Links
Oramed Pharmaceuticals Appoints Dr. Michael Berelowitz as Chairman of Scientific Advisory Board
Date:6/22/2011

y new role at Oramed. Since joining the Board of Directors in 2010, I have had a chance to get to know the management team and work closely with them towards achieving their goals.  I look forward to helping the company progress and develop novel therapies to serve the large and growing numbers of people who suffer from diabetes. "

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines presently delivered via injection. Oramed is seeking to revolutionize the treatment of diabetes through its patented flagship product, an orally ingestible insulin capsule currently in Phase 2 clinical trials. Established in 2006, Oramed's technology is based on over 25 years of research performed by top research scientists at Jerusalem's Hadassah Medical Center. The Company's corporate and R&D headquarters are based in Jerusalem.

For more information, please visit http://www.oramed.com

Safe Harbor Statement

Some of the statements contained in this press release are forward-looking statements which involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for our product candidates; competition from other pharmaceutical or biotechnology companies; and the company's ability to obtain additional funding required to conduct its research, development and commercialization activities. Please refer to the company's filings with the Securities and Exchange Commission for a comprehensive list of r
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oramed Pharmaceuticals Partners With ETI Karle Clinical to Conduct Phase 2B Trials on Its Oral Insulin Capsule, ORMD 0801
2. Oramed Pharmaceuticals to Present at Rodman & Renshaw Healthcare Conference (November 11, 2008; NYC)
3. Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients
4. Oramed Pharmaceuticals was Awarded a NIS 3.1 Million Grant From the Israeli Office of the Chief Scientist
5. Frost and Sullivan Honors Oramed Pharmaceuticals With the 2009 European Oral Drug Delivery Technology Innovation Award
6. Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference
7. Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog
8. Orameds Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland
9. Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients
10. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
11. Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Boston, MA (PRWEB) January 14, 2014 ... today announces Michelle Detwiler as the new Director of ... current and potential clients as well as iLab sub-teams ... main goal will be to ensure that iLab provides ... offering the most advanced, user-friendly, and high-impact solution in ...
(Date:1/14/2014)... WESTBOROUGH, Mass. , Jan. 14, 2014 ... biotechnology company focused on discovering, developing and ... needs using RNA-targeted technologies, today announced that ... the United States Patent and Trademark Office ... for the treatment of fibrosis. The patent ...
(Date:1/14/2014)... , Jan. 14, 2014   Kinaxis ®, ... management ( SCM ) and sales and operations planning ... gold sponsor of the Biomanufacturing Summit , which ... January 30 – 31, 2014.  At the conference, join ... Chain at Amgen, as she presents ,Supply Chain: Improving ...
(Date:1/14/2014)... Kerr Corporation, a leading manufacturer of innovative dental products, ... dual arch impressions on its dental blog. , ... entry serves up a list of tips to help dentists ... Dr. David Little as he crafts a porcelain crown using ... as the dual arch dental impression material . ...
Breaking Biology Technology:iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... RainDance Technologies, Inc.,a provider of innovative droplet-based ... announced that the J. Craig Venter,Institute (JCVI), a ... MD and La Jolla, CA, will become an ... and Sequence Enrichment application., Under the Early ...
... BREAKING NEWS: Paige Padgett has,been selected as one of ... Awards on November 13th at The Ebell of Los ... Blush, lipstick, eye shadow - check. Ecological impact... who ... eco-conscious often doesn,t,happen in the bathroom. Up to 60% ...
... ultra-high definition has potential to revolutionize,endoscopic surgery, ... a glimpse into the,future of women,s healthcare with ... the first time using "4K" technology, at the ... the AAGL. AAGL,is the international professional society for ...
Cached Biology Technology:RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI 2RainDance Technologies Delivers RDT 1000, Sequence Enrichment Solution to JCVI 3Green Makeup Artist Paige Padgett Says, 'Get Smart' 2Women's Surgery Recorded for the First Time on '4K' Digital Cinema is Presented at the AAGL Congress 2
(Date:4/15/2014)... the question of how social behavior has developed over ... Mainz and Basel have gained new insights from the ... for food. Rather the siblings share what is available ... Dr. Jol Meunier of the Evolutionary Biology section of ... Mainz (JGU). The team of biologists from Mainz University ...
(Date:4/15/2014)... MA -- Delivering chemotherapy drugs in nanoparticle form could ... to the tumors. In recent years, scientists have developed ... it has been difficult to design particles that ... ratio. , Now MIT chemists have devised a new ... to include three or more different drugs. In a ...
(Date:4/15/2014)... that the genetic code is far more complex ... building blocks adenine, cytosine, guanine, and thymine, numerous ... assume that the newly discovered nucleic acid modifications ... extends and complements the genetic code. "The new ... standard alphabet," explained Professor Mark Helm of the ...
Breaking Biology News(10 mins):Sibling cooperation in earwig families gives clues to early evolution of social behavior 2Targeting cancer with a triple threat 2Targeting cancer with a triple threat 3German Research Foundation approves new priority program in the life sciences 2
... Troy, N.Y. Researchers at Rensselaer Polytechnic Institute ... the first-ever virtual reality simulator for next-generation "scarless" ... the U.S. National Institutes of Health (NIH), seeks ... endoscopic surgery, or NOTES. This emerging surgical technique ...
... new genetic clues on risk factors and biological causes ... (PSP), according to a new study from an international ... of Medicine at the University of Pennsylvania. In the ... associated with risk for PSP were identified and two ...
... 2011)Mitochondria, those battery-pack organelles that fuel the energy of ... calcium. Whether in a dish or a living organism, ... compound. Because calcium levels link to many essential biological ... diabetesscientists have been working for half a century to ...
Cached Biology News:Rensselaer researchers secure $2.7 million NIH grant to advance 'scarless' surgery 2Rensselaer researchers secure $2.7 million NIH grant to advance 'scarless' surgery 3New genes for risk and progression of rare brain disease identified 2New genes for risk and progression of rare brain disease identified 350-year search for calcium channel ends 250-year search for calcium channel ends 3
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
... HDAC8 Regulation of gene expression ... as DNA methylation, ATP-dependent chromatin remodeling, ... which include the dynamic acetylation and ... residues present in the tail of ...
... raised against a partial recombinant ... SLC22A3 (NP_068812, 90 a.a. ... protein with GST tag. ... NM_021977 Protein ...
...
Biology Products: